Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine vs Povidone Iodine for Blood Culture Contamination in Pediatrics
NCT01919593Phase 4
Key facts
- Status
- Completed
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Countries
- 1
- Sponsor
- Thammasat University
- Modality
- Small Molecules
- Drugs
- chlorhexidine
- Conditions
- Bacteremia
01
Overview
Phase 4, open-label trial of chlorhexidine in Bacteremia (2 arms), sponsored by Thammasat University. Primary endpoint: Efficacy of 2% chlorhexidine gluconate in 70% alcohol compared with 10% povidone iodine at 5 days. Started Jan 2012; status: completed.
02
Design
2 arms- Study design
- Non-randomizedOpen-label
2% Chlorhexidine Gluconate
Applied to skin before venipuncture in even months
10% Povidone Iodine
Applied to skin before venipuncture in odd months
03
Who it enrols
Pediatric patients aged 0-15 years admitted to general pediatric wards or PICU requiring percutaneous blood cultures, excluding preterm infants and those with skin infections at the venepuncture site or allergies to the antiseptics.
04
Endpoints
Primary
Efficacy of 2% chlorhexidine gluconate in 70% alcohol compared with 10% povidone iodine
Secondary
Safety of 2% chlorhexidine gluconate in 70% alcohol compared with 10% povidone iodine
Beyond the preview
Go deeper on NCT01919593.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919593.